Avalon globocare and university of natural resources and life sciences (boku) expand partnership and accelerate development of s-layer based vaccines and cellular therapeutics

Freehold, n.j., dec. 30, 2020 (globe newswire) -- avalon globocare corp. (nasdaq: avco) (avalon or the company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced an update on its partnership with the institute for synthetic bioarchitectures at the university of natural resources and life sciences (boku) in vienna, austria. the collaboration brings together boku's s-layer nanotechnology with avalon's expertise in biomanufacturing, cell therapy engineering, and clinical development.
AVCO Ratings Summary
AVCO Quant Ranking